Implementing the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: SGLT2 Inhibitors, Treatment Sequencing, and Value Statements
A Q&A With Paul Heidenreich, MD
A Q&A With Milton Packer, MD
A Q&A With Gary Besinque, PharmD
Advertisement
Advertisement
Trending on AJMC
1
Ebola Cases Top 1700 as Unpaid Health Workers Strike
2
Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers
3
FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6
4
Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies
5